athenahealth, Inc. (NASDAQ: ATHN) Investor Investigation Over Potential Wrongdoing In Acquisition

Investors who purchased shares of athenahealth, Inc. (NASDAQ: ATHN) and currently hold any of those NASDAQ: ATHN shares have certain options and should contact the Shareholders Foundation, Inc.

To have your information reviewed for options and to recieve notifications about this investigation, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Company Name(s): 
athenahealth
Affected Securities: 
NASDAQ: ATHN

An investigation on behalf of investors, who currently hold shares of athenahealth, Inc. (NASDAQ: ATHN), was announced concerning whether the takeover of athenahealth, Inc. is unfair to NASDAQ: ATHN stockholders.

The investigation by a law firm concerns whether certain officers and directors of athenahealth, Inc. breached their fiduciary duties owed to NASDAQ: ATHN investors in connection with the proposed acquisition.

On November 12, 2018, athenahealth, Inc. (NASDAQ: ATHN), Veritas Capital and Evergreen Coast Capital announced that they have entered into an agreement under which an affiliate of Veritas Capital and Evergreen Coast Capital will acquire athenahealth for approximately $5.7 billion in cash. Under the terms of the agreement, athenahealth shareholders will receive $135 in cash per share.

However, given that at least one analyst has set the high target price for NASDAQ: ATHN shares at $179 per share and given that NASDAQ: ATHN shares traded in the open market as recently as July 2018 as high as $162.54 per share, the investigation concerns whether the offer is unfair to athenahealth, Inc. (NASDAQ: ATHN stockholders. More specifically, the investigation concerns whether the athenahealth, Inc. (NASDAQ: ATHN Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.

athenahealth, Inc. reported that its annual Total Revenue rose from over $1.08 billion in 2016 to over $1.22 billion in 2017 and that its Net Income increased from $21 million in 2016 to $53.1 million in 2017.